CATEGORY : Biomarkers

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

ASHG 2019: DeciBio Highlights

We just returned from ASHG 2019 in Houston and while the city provided a lot of excitement with the Astro’s headed to the World Series, the meeting itself lacked any

Four Calls-to-Action for Digital Disrupters from #RHSUM19

Healthcare entrants, primarily startups and tech incumbents, came to the forefront of discussion at last week’s Rock Health Summit. As entrants emerge, healthcare is adapting to a proliferation of choice

I/O Biomarker Spotlight: Digital Pathology and Multiplex Spatial Tissue Analysis

We’ve noticed a trend in the oncology biomarker this year.  Both anecdotally, through our observations and discussions at AGBT and AACR and with our network of industry KOLs, and analytically,

An Updated Look at TMB: What Has Changed and What to Expect

Since we last reported on the rise of tumor mutational burden (TMB) in immuno-oncology (I/O) a year ago, there have been numerous material developments of this biomarker in the I/O

AACR 2019: DeciBio Highlights

A month ago, we attended AGBT 2019 and observed a strong interest in spatial profiling and single cell analysis. While we recognize that we are somewhat biased by the in-person

Pulse Survey: Adoption and Utilization of Next Generation Cancer Biomarkers

The way cancer is diagnosed, treated, and monitored is changing more rapidly than ever. In 2019, we expect there to be catalysts that fundamentally change cancer companion diagnostic biomarker testing (i.e.,

Three lessons for digital health entrepreneurs from #RHSUM18

This year’s Rock Health annual digital health summit showcased another impressive lineup, with speakers like Bernard Tyson (CEO of Kaiser Permanente), Toby Cosgrove (Executive Adviser for Google Cloud and former

The Implications and Benefits of Early Identification of Alzheimer’s Disease

Editor’s Note: This article was written by Trpti Sanghvi, who was part of DeciBio’s summer 2018 intern class. She will graduate in Spring 2019 with a degree in Neuroscience. Alzheimer’s